Tag: circulating tumor cells market size

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The circulating tumor cells market is experiencing significant growth, driven by advances in cancer diagnostics and increasing research activities. As healthcare continues to prioritize early detection and personalized treatment, this market is positioned for substantial expansion. Below is a detailed overview of the market size, key growth drivers, prominent segments, emerging innovations, leading companies, and regional outlook.

Projected Growth and Market Size of the Circulating Tumor Cells Market

The circulating tumor cells market has witnessed rapid expansion recently and is anticipated to continue this trajectory. It is expected to rise from $13.27 billion in 2025 to $14.99 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.0%. This strong growth during the historical period is attributed to the rising incidence of cancer, the broadening scope of oncology research initiatives, increased use of blood-based diagnostic methods, growing preference for minimally invasive testing, and advancements in laboratory technologies. Looking ahead, the market is forecasted to reach $23.88 billion by 2030, growing at a CAGR of 12.3%. Factors fueling future growth include the increasing uptake of personalized oncology diagnostics, more investments in cancer biomarker research, advances in automated cell capture technologies, rising demand for early cancer detection tools, and the integration of artificial intelligence in oncology diagnostics. Key trends anticipated in the forecast period include wider adoption of liquid biopsy techniques, greater use of microfluidic devices for isolating circulating tumor cells, expansion of automated analysis systems, growing applications in oncology research, and an intensified focus on detecting cancer early.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Rising Cancer Incidence as a Primary Growth Driver in the Circulating Tumor Cells Market

One of the dominant factors propelling the circulating tumor cells market is the increasing prevalence of cancer worldwide. Cancer involves abnormal and uncontrollable cell growth that spreads throughout the body. Circulating tumor cells play a crucial role in facilitating early cancer detection and diagnosis, which directly stimulates demand for related diagnostic technologies. For example, in February 2024, the World Health Organization, a global health policy organization based in Switzerland, projected over 35 million new cancer cases by 2050. This figure represents a 77% increase from the estimated 20 million cases recorded in 2022. Such a dramatic rise in cancer incidence underscores the expanding need for circulating tumor cell diagnostics and is a key catalyst for market growth.

Additional Factors Supporting Expansion in the Circulating Tumor Cells Market

Beyond cancer prevalence, several other elements are driving market development. These include the widespread adoption of blood-based, minimally invasive diagnostics that are preferred for patient comfort and early detection efficiency. The growing oncology research ecosystem, including biomarker discovery and validation, is also expanding the demand for circulating tumor cell technologies. Additionally, technological improvements such as advanced microfluidic isolation and automated analysis systems are making these diagnostic tools more accessible and reliable, further encouraging their uptake in clinical and research settings.

Access The Complete Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Detailed Segmentation of the Circulating Tumor Cells Market

The circulating tumor cells market is defined by several key segments that help identify opportunities and areas of focus:

1) Product Types: Kits and Reagents, Blood Collection Tubes, Devices or Systems

2) Technology Categories: CTC Enrichment, CTC Detection, CTC Analysis

3) Application Areas: Clinical or Liquid Biopsy, and Research

Within product types, kits and reagents include subcategories such as cell enrichment kits, detection kits, and nucleic acid isolation kits. Blood collection tubes are divided into standard and specialized types. Devices and systems comprise microfluidic devices, automated cell capture systems, and imaging systems. This segmentation offers a comprehensive framework for understanding market dynamics and innovation focus.

Innovative Advances Shaping the Circulating Tumor Cells Market

Leading companies in the circulating tumor cells space are developing cutting-edge solutions to meet the growing demand for precise and non-invasive cancer diagnostics. One key innovation is biomarker-specific circulating tumor cell assays, which provide more detailed information by detecting protein expression on tumor cells, rather than simply counting total cells. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics firm, introduced the CELLSEARCH CTC test featuring the DLL3 biomarker. Available as a Research Use Only (RUO) service in North America and Europe, this test utilizes the FDA-cleared CELLSEARCH platform to identify circulating tumor cells expressing DLL3—a protein linked to aggressive small-cell lung cancer and neuroendocrine tumors. This assay allows researchers to characterize tumor cell subtypes with poor prognosis, facilitating biopharma research focused on targeted therapies. Such innovations offer vital tools for studying tumor heterogeneity, tracking disease progression, and assessing responses to personalized treatments.

Key Market Players Driving the Circulating Tumor Cells Industry

The circulating tumor cells market features numerous influential companies contributing to research, development, and commercialization of diagnostic solutions. Some prominent names include BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, and Agilent Technologies Inc. These companies play a pivotal role in advancing circulating tumor cell technologies and expanding their clinical applications.

Regional Landscape and Market Growth Prospects for Circulating Tumor Cells

In 2025, North America is expected to maintain its position as the largest market for circulating tumor cells, driven by strong healthcare infrastructure, extensive oncology research, and high adoption of advanced diagnostics. Meanwhile, the Asia-Pacific region is forecasted to be the fastest-growing market during the projection period, fueled by increasing awareness, expanding healthcare access, and rising investments in cancer diagnostics. The market analysis encompasses key geographic areas including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, presenting a global perspective on market evolution.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Circulating Tumor Cells Market During The Forecast Period?

The circulating tumor cells market size has seen swift expansion in recent years. It is projected to grow from $13.27 billion in 2025 to $14.99 billion in 2026, with a compound annual growth rate (CAGR) of 13.0%. The growth observed in previous periods can be attributed to factors such as increasing cancer incidence rates, the expansion of oncology research programs, the growing application of blood-based diagnostics, a rising adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The market size for circulating tumor cells is projected to experience swift expansion over the coming years, anticipated to reach $23.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. The expansion anticipated during the forecast period is fueled by factors such as the greater acceptance of personalized oncology diagnostics, increased funding in cancer biomarker research, the proliferation of automated cell capture technologies, a rising need for tools capable of early-stage cancer detection, and the growing incorporation of AI in oncology diagnostics. Key trends identified for this period encompass the increased application of liquid biopsy techniques, a growing uptake of microfluidic CTC isolation devices, the broader integration of automated CTC analysis systems, an expansion in oncology research applications, and a heightened emphasis on the early detection of cancer.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Core Factors Are Supporting The Expansion Of The Circulating Tumor Cells Market?

The increasing incidence of cancer is anticipated to propel the circulating tumor cells market growth in the coming period. Cancer is defined as a condition where certain body cells multiply uncontrollably and spread to other areas of the body. Circulating tumor cells play a role in the early detection and diagnosis of cancer, thus the rising occurrence of cancer drives the expansion of the circulating tumor cells market. For instance, in February 2024, the World Health Organization, a Switzerland-based international organization dedicated to global health policy and public health initiatives, predicted over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is fueling the growth of the circulating tumor cells market.

How Are Different Segment Groups Identified Within The Circulating Tumor Cells Market?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Which Trends Are Guiding The Development Of The Circulating Tumor Cells Market?

Major companies within the circulating tumor cells (CTC) market are concentrating on creating innovative solutions, such as biomarker-specific CTC assays, to address the growing need for precise, non-invasive cancer diagnostics and advanced personalized therapy monitoring. Biomarker-specific CTC assays facilitate the identification and profiling of circulating tumor cells based on particular protein expression, offering more detailed phenotypic information compared to traditional CTC enumeration methods, which primarily provide total cell counts without distinguishing biomarkers. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, launched the CELLSEARCH CTC test featuring the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. This assay utilizes the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein highly expressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test allows for phenotypic characterization of CTCs associated with poor prognosis, assisting biopharma research in developing targeted therapies. This advancement provides researchers with a non-invasive instrument to investigate tumor heterogeneity, track disease progression, and assess the effectiveness of targeted treatments.

Who Are The Companies Shaping The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Access The Complete Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regional Market Leads The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Circulating Tumor Cells Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Circulating Tumor Cells Market Expected To Scale Between 2026 And 2030?

The circulating tumor cells market has seen substantial growth over recent years. It is anticipated to expand from $13.27 billion in 2025 to $14.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. This historical expansion can be attributed to several factors including rising cancer incidence rates, the broadening of oncology research programs, an increasing reliance on blood-based diagnostics, the greater adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The circulating tumor cells market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $23.88 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period can be attributed to several factors, including the increasing uptake of personalized oncology diagnostics, greater investments in cancer biomarker research, the proliferation of automated cell capture technologies, a rising demand for tools to detect cancer at early stages, and the increasing incorporation of AI in oncology diagnostics. Significant trends for this period encompass the growing utilization of liquid biopsy techniques, an increase in the adoption of microfluidic CTC isolation devices, the expanding integration of automated CTC analysis systems, a broader application of oncology research, and a heightened emphasis on the early detection of cancer.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Significant Factors Are Influencing The Circulating Tumor Cells Market Expansion?

The increasing occurrence of cancer is projected to drive the expansion of the circulating tumor cells market in the future. Cancer is defined as an illness where certain body cells proliferate without control and disseminate to various regions. Circulating tumor cells play a role in the early identification and diagnosis of cancer, consequently, the rising prevalence of cancer fuels the expansion of the circulating tumor cells market. To illustrate, data from February 2024 by the World Health Organization, an international organization based in Switzerland focused on global health policy and public health initiatives, forecasts more than 35 million new cancer cases by 2050, representing a 77% rise from the approximately 20 million cases estimated in 2022. Thus, the rising rate of cancer incidence is a key factor propelling the development of the circulating tumor cells market.

How Is The Circulating Tumor Cells Market Segmented Across Different Segment Categories?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Trends Are Affecting The Direction Of The Circulating Tumor Cells Market?

Key companies in the circulating tumor cells (CTC) market are concentrating on developing innovative solutions, such as biomarker-specific CTC assays, to fulfill the increasing need for precise, non-invasive cancer diagnostics and advanced personalized therapy monitoring. These biomarker-specific CTC assays enable the identification and characterization of circulating tumor cells based on specific protein expression, providing more detailed phenotypic information than traditional CTC enumeration methods, which primarily offer total cell counts without distinguishing biomarkers. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, introduced the CELLSEARCH CTC test with the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. The assay employs the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test facilitates phenotypic characterization of CTCs associated with poor prognosis, thereby supporting biopharma research in developing targeted therapies. This innovation offers researchers a non-invasive tool to investigate tumor heterogeneity, monitor disease progression, and evaluate response to targeted treatments.

Which Organizations Play A Role In The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Get The Full Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Holds The Highest Market Share In The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Circulating Tumor Cells Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Circulating Tumor Cells Market Expected To Scale Between 2026 And 2030?

The circulating tumor cells market has seen substantial growth over recent years. It is anticipated to expand from $13.27 billion in 2025 to $14.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. This historical expansion can be attributed to several factors including rising cancer incidence rates, the broadening of oncology research programs, an increasing reliance on blood-based diagnostics, the greater adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The circulating tumor cells market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $23.88 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period can be attributed to several factors, including the increasing uptake of personalized oncology diagnostics, greater investments in cancer biomarker research, the proliferation of automated cell capture technologies, a rising demand for tools to detect cancer at early stages, and the increasing incorporation of AI in oncology diagnostics. Significant trends for this period encompass the growing utilization of liquid biopsy techniques, an increase in the adoption of microfluidic CTC isolation devices, the expanding integration of automated CTC analysis systems, a broader application of oncology research, and a heightened emphasis on the early detection of cancer.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Significant Factors Are Influencing The Circulating Tumor Cells Market Expansion?

The increasing occurrence of cancer is projected to drive the expansion of the circulating tumor cells market in the future. Cancer is defined as an illness where certain body cells proliferate without control and disseminate to various regions. Circulating tumor cells play a role in the early identification and diagnosis of cancer, consequently, the rising prevalence of cancer fuels the expansion of the circulating tumor cells market. To illustrate, data from February 2024 by the World Health Organization, an international organization based in Switzerland focused on global health policy and public health initiatives, forecasts more than 35 million new cancer cases by 2050, representing a 77% rise from the approximately 20 million cases estimated in 2022. Thus, the rising rate of cancer incidence is a key factor propelling the development of the circulating tumor cells market.

How Is The Circulating Tumor Cells Market Segmented Across Different Segment Categories?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Trends Are Affecting The Direction Of The Circulating Tumor Cells Market?

Key companies in the circulating tumor cells (CTC) market are concentrating on developing innovative solutions, such as biomarker-specific CTC assays, to fulfill the increasing need for precise, non-invasive cancer diagnostics and advanced personalized therapy monitoring. These biomarker-specific CTC assays enable the identification and characterization of circulating tumor cells based on specific protein expression, providing more detailed phenotypic information than traditional CTC enumeration methods, which primarily offer total cell counts without distinguishing biomarkers. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, introduced the CELLSEARCH CTC test with the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. The assay employs the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test facilitates phenotypic characterization of CTCs associated with poor prognosis, thereby supporting biopharma research in developing targeted therapies. This innovation offers researchers a non-invasive tool to investigate tumor heterogeneity, monitor disease progression, and evaluate response to targeted treatments.

Which Organizations Play A Role In The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Get The Full Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Holds The Highest Market Share In The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Circulating Tumor Cells Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Circulating Tumor Cells Market Expected To Scale Between 2026 And 2030?

The circulating tumor cells market has seen substantial growth over recent years. It is anticipated to expand from $13.27 billion in 2025 to $14.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. This historical expansion can be attributed to several factors including rising cancer incidence rates, the broadening of oncology research programs, an increasing reliance on blood-based diagnostics, the greater adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The circulating tumor cells market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $23.88 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period can be attributed to several factors, including the increasing uptake of personalized oncology diagnostics, greater investments in cancer biomarker research, the proliferation of automated cell capture technologies, a rising demand for tools to detect cancer at early stages, and the increasing incorporation of AI in oncology diagnostics. Significant trends for this period encompass the growing utilization of liquid biopsy techniques, an increase in the adoption of microfluidic CTC isolation devices, the expanding integration of automated CTC analysis systems, a broader application of oncology research, and a heightened emphasis on the early detection of cancer.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Significant Factors Are Influencing The Circulating Tumor Cells Market Expansion?

The increasing occurrence of cancer is projected to drive the expansion of the circulating tumor cells market in the future. Cancer is defined as an illness where certain body cells proliferate without control and disseminate to various regions. Circulating tumor cells play a role in the early identification and diagnosis of cancer, consequently, the rising prevalence of cancer fuels the expansion of the circulating tumor cells market. To illustrate, data from February 2024 by the World Health Organization, an international organization based in Switzerland focused on global health policy and public health initiatives, forecasts more than 35 million new cancer cases by 2050, representing a 77% rise from the approximately 20 million cases estimated in 2022. Thus, the rising rate of cancer incidence is a key factor propelling the development of the circulating tumor cells market.

How Is The Circulating Tumor Cells Market Segmented Across Different Segment Categories?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Trends Are Affecting The Direction Of The Circulating Tumor Cells Market?

Key companies in the circulating tumor cells (CTC) market are concentrating on developing innovative solutions, such as biomarker-specific CTC assays, to fulfill the increasing need for precise, non-invasive cancer diagnostics and advanced personalized therapy monitoring. These biomarker-specific CTC assays enable the identification and characterization of circulating tumor cells based on specific protein expression, providing more detailed phenotypic information than traditional CTC enumeration methods, which primarily offer total cell counts without distinguishing biomarkers. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, introduced the CELLSEARCH CTC test with the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. The assay employs the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test facilitates phenotypic characterization of CTCs associated with poor prognosis, thereby supporting biopharma research in developing targeted therapies. This innovation offers researchers a non-invasive tool to investigate tumor heterogeneity, monitor disease progression, and evaluate response to targeted treatments.

Which Organizations Play A Role In The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Get The Full Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Holds The Highest Market Share In The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Circulating Tumor Cells Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Circulating Tumor Cells Market Expected To Change Between 2026 And 2030?

The circulating tumor cells market has observed rapid expansion in its size over recent years. It is projected to expand from $13.27 billion in 2025 to $14.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.0%. This historical expansion can be ascribed to several factors: increasing cancer incidence rates, the expansion of oncology research programs, the growing use of blood-based diagnostics, the rising adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The circulating tumor cells market size is expected to witness significant expansion in the coming years. It is projected to grow to **$23.88 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%**. This growth during the forecast period can be attributed to the rising adoption of personalized oncology diagnostics, increasing investments in cancer biomarker research, the expansion of automated cell capture technologies, a growing demand for early-stage cancer detection tools, and the increasing integration of artificial intelligence in oncology diagnostics. Key trends expected over the forecast period include the increasing use of liquid biopsy techniques, a rise in the adoption of microfluidic CTC isolation devices, the growing integration of automated CTC analysis systems, the expansion of oncology research applications, and an enhanced focus on early cancer detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Underlying Factors Are Accelerating The Growth Of The Circulating Tumor Cells Market?

The increasing occurrence of cancer is projected to drive the expansion of the circulating tumor cells market in the future. Cancer is defined as a condition where certain body cells multiply without control and disseminate to various regions. Circulating tumor cells assist in the prompt identification and diagnosis of cancer; consequently, the rising prevalence of cancer fuels the development of the circulating tumor cells market. For example, data from February 2024, published by the World Health Organization – an international entity based in Switzerland focused on global health policy and public health efforts – indicates that more than 35 million new cancer cases are anticipated by 2050. This represents a 77% surge from the approximately 20 million cases recorded in 2022. As a result, the rising incidence of cancer is a key factor propelling the expansion of the circulating tumor cells market.

How Is The Circulating Tumor Cells Market Structured Across Different Segments?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Which Trends Are Shaping The Future Of The Circulating Tumor Cells Market?

Leading companies in the circulating tumor cells (CTC) market are concentrating on developing advanced solutions, such as biomarker-specific CTC assays, to address the increasing need for precise, non-invasive cancer diagnostics and sophisticated personalized therapy monitoring. Biomarker-specific CTC assays enable the identification and characterization of circulating tumor cells based on specific protein expression, yielding more comprehensive phenotypic data than traditional CTC enumeration methods, which primarily offer total cell counts without biomarker differentiation. For example, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, released the CELLSEARCH CTC test with the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. This assay utilizes the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein that is overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test facilitates the phenotypic characterization of CTCs associated with poor prognosis, thereby supporting biopharma research in the development of targeted therapies. This innovation offers researchers a non-invasive instrument for studying tumor heterogeneity, monitoring disease progression, and assessing responses to targeted treatments.

Which Major Players Dominate The Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Read the full circulating tumor cells market report here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Is Projected To Dominate The Circulating Tumor Cells Market During The Forecast Period?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Circulating Tumor Cells Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Circulating Tumor Cells Market by the end of 2030?

The circulating tumor cells market size has expanded considerably in recent years. It is forecast to grow from $13.27 billion in 2025 to $14.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. The historical increase can be linked to higher cancer incidence rates, the expansion of oncology research initiatives, the broader application of blood-based diagnostics, an increasing preference for minimally invasive testing approaches, and the accessibility of advanced laboratory technologies.

The circulating tumor cells market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $23.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period is primarily driven by factors such as the increasing acceptance of personalized oncology diagnostics, growing investments in cancer biomarker research, the broader deployment of automated cell capture technologies, a rising need for tools capable of detecting cancer at early stages, and the expanding integration of artificial intelligence within oncology diagnostics. Key trends anticipated in this period encompass the increased application of liquid biopsy techniques, the rising embrace of microfluidic CTC isolation devices, the expanding integration of automated CTC analysis systems, the broader scope of oncology research applications, and a heightened emphasis on early cancer detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Drivers Are Shaping Future Opportunities In The Circulating Tumor Cells Market?

The expansion of the circulating tumor cells market is anticipated to be propelled by the increasing occurrence of cancer moving forward. Cancer is defined as a condition where certain body cells multiply uncontrollably and spread to other parts. Circulating tumor cells are instrumental in aiding the early detection and diagnosis of cancer, and thus, the rising incidence of cancer propels the growth of the circulating tumor cells market. For instance, in February 2024, the World Health Organization, an international organization based in Switzerland specializing in global health policy and public health initiatives, predicted over 35 million new cancer cases in 2050, which represents a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is driving the growth of the circulating tumor cells market.

Which Segments Are Gaining Traction In The Circulating Tumor Cells Market?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Which Trends Are Influencing The Performance And Direction Of The Circulating Tumor Cells Market?

Leading companies within the circulating tumor cells (CTC) market are concentrating on creating novel solutions, such as biomarker-specific CTC assays, to address the increasing need for accurate, non-invasive cancer diagnosis and sophisticated personalized therapy tracking. These biomarker-specific CTC assays facilitate the identification and characterization of circulating tumor cells through particular protein expression, providing richer phenotypic data compared to conventional CTC enumeration techniques, which primarily offer total cell counts without distinguishing biomarkers. As an illustration, in July 2023, Menarini Silicon Biosystems S.p.A., a diagnostics firm based in Italy, unveiled the CELLSEARCH CTC test incorporating the DLL3 biomarker, which is presently accessible as a Research Use Only (RUO) service across North America and Europe. This assay utilizes the FDA-cleared CELLSEARCH platform to identify circulating tumor cells that express DLL3, a protein frequently overexpressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By concentrating on DLL3, the test enables the phenotypic characterization of CTCs associated with unfavorable prognoses, thereby assisting biopharma research in the development of targeted therapies. This innovation provides researchers with a non-invasive instrument to investigate tumor heterogeneity, track disease progression, and assess responses to targeted treatments.

Who Are The Core Companies Influencing Trends In The Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regions Are Projected To Dominate The Circulating Tumor Cells Market In The Coming Years?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Circulating Tumor Cells Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the circulating tumor cells market from 2025–2034 with trusted insights from The Business Research Company

How Is The Circulating Tumor Cells Market Size Expected To Expand Over 2029-2034?

The market for circulating tumor cells has experienced substantial expansion in recent years. This market is projected to expand from $11.9 billion in 2024 to reach $13.27 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 11.5%. Historically, this growth has been driven by factors such as the increasing incidence and prevalence of cancer, the clinical utility in cancer staging, the emergence of liquid biopsy techniques, patient demand for minimally invasive tests, regulatory support for liquid biopsies, and a strong focus on early cancer detection.

The circulating tumor cells market is projected to experience substantial expansion over the upcoming years, anticipating a rise to $21.38 billion by 2029, driven by a compound annual growth rate (CAGR) of 12.7%. This growth throughout the forecast period is attributable to point-of-care CTC testing, the increased adoption of microfluidics, a concentrated focus on rare cancer types, the standardization of CTC assays, the expansion of CTC-based clinical trials, and economic and emerging market growth. Prominent trends for the forecast period involve innovations in CTC isolation techniques, government funding allocated for CTC research, advancements in CTC detection technologies, the use of liquid biopsy for cancer monitoring, integration with single-cell analysis, and technological convergence with artificial intelligence (AI).

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Market Factors Are Fueling The Circulating Tumor Cells Industry Growth?

The expansion of the circulating tumor cells market is anticipated due to the increasing occurrence of cancer. Cancer is a condition where certain body cells proliferate uncontrollably and spread to other areas. Circulating tumor cells assist in the early identification and diagnosis of cancer, thus the rising prevalence of cancer fuels the growth of the circulating tumor cells market. For instance, in January 2023, the American Cancer Society Journals, a US-based voluntary health organization, projected 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. Consequently, the growing incidence of cancer is a key driver for the circulating tumor cells market’s growth.

Which Categories Are Covered In The Circulating Tumor Cells Market Segmentation Analysis?

The circulating tumor cellsmarket covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Which Market Trends Are Expected To Define The Future Of The Circulating Tumor Cells Market?

Product innovation represents a pivotal trend gaining significant traction within the circulating tumor cells market. Key companies active in the circulating tumor cells market are concentrating on developing groundbreaking products to reinforce their market standing. An illustration of this is the launch of Celselect Slides 2.0 by Bio-Rad Laboratories, Inc., a US-based medical laboratory, in June 2024. This product is specifically designed to improve the capture of rare cells and circulating tumor cells (CTCs), thereby boosting the accuracy and efficiency of cell analysis in both clinical and research settings.

Which Organizations Are At The Forefront Of The Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Spinal Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Circulating Tumor Cells Market Size Likely To Evolve From 2025 Through 2034?

The market encompassing circulating tumor cells has experienced swift expansion lately; projections show it advancing from a valuation of $11.9 billion in 2024 to $13.27 billion by 2025, reflecting an 11.5% compound annual growth rate. This historical upswing is powered by several factors, including the rising frequency and widespread occurrence of cancer, the value of these cells in determining cancer progression stages, the development of liquid biopsy techniques, the preference among patients for procedures that involve less invasiveness, supportive actions from regulatory bodies regarding liquid biopsies, and a concentrated effort towards identifying cancer much earlier.

Projections indicate that the market for circulating tumor cells is poised for swift expansion in the forthcoming years, escalating to a valuation of $21.38 billion by 2029, driven by a compound annual growth rate (CAGR) of 12.7%.This forthcoming growth is fundamentally supported by several key factors, such as the burgeoning use of CTC testing at the point of care, increasing incorporation of microfluidic technologies, a heightened concentration on less common cancer categories, the effort to standardize various CTC assay procedures, the proliferation of clinical trials utilizing CTCs, and expansion within both developed and burgeoning economies.Significant developments anticipated throughout this forecast duration encompass novel developments in isolating circulating tumor cells, increased governmental financial support channeled toward CTC investigation, progress in the methods used to identify these cells, the utilization of liquid biopsy for ongoing cancer surveillance, the merging of CTC analysis with resolution at the single-cell level, and the technological synergy realized by integrating artificial intelligence (AI).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Drivers Are Shaping The Circulating Tumor Cells Industry’s Market Share?

The escalating frequency of cancer cases is projected to be a key catalyst for the expansion of the market for circulating tumor cells in the foreseeable future. Cancer, fundamentally characterized by the uncontrolled proliferation and subsequent dissemination of certain bodily cells, relies on circulating tumor cell technologies for its early identification and accurate diagnosis, thereby directly fueling market expansion as cancer rates rise. To illustrate this trend, data provided in January 2023 by the American Cancer Society Journals, a prominent US non-profit health entity, indicated an anticipation of 1,958,310 new cancer diagnoses and an estimated 609,820 cancer fatalities within the United States, underscoring why the increasing prevalence of cancer strongly motivates the growth trajectory of the circulating tumor cells market.

What Are The Primary Types Of Segments Analyzed In The Circulating Tumor Cells Market?

The circulating tumor cellsmarket covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Are The Major Trends Driving The Growth Of The Circulating Tumor Cells Market?

A significant movement within the circulating tumor cells sector involves advancements in product offerings. Leading firms actively participating in this market are concentrating their efforts on engineering novel solutions to solidify their competitive standing. Demonstrating this drive, in the month of June in 2024, Bio-Rad Laboratories, Inc., an American firm specializing in medical diagnostics, introduced the Celselect Slides 2.0, a device engineered specifically to boost the isolation of scarce cells and circulating tumor cells, consequently boosting the precision and effectiveness of cell evaluation for both medical practice and scientific inquiry.

Who Are The Core Companies Influencing The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Is Projected To Lead The Circulating Tumor Cells Market During The Forecast Period?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Spinal Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Circulating Tumor Cells Market From 2025 To 2029?

There has been a rapid expansion in the size of the circulating tumor cells market in the past few years. The market, which was valued at $11.9 billion in 2024, is expected to rise to $13.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.5%. The growth seen in this historic period can be traced back to factors such as the rate of cancer occurrence, the role of clinical utility in cancer staging, the advent of liquid biopsy, the patient preference for minimally invasive tests, regulatory encouragement for liquid biopsies, and an emphasis on detecting cancer early.

Expectations are high for a swift expansion in the circulating tumor cells market in the coming years, with predictions placing it at $21.38 billion by 2029, reflecting a compound annual growth rate of 12.7%. Factors influencing this predicted increase during the projected term, included the utilization of point-of-care CTC tests, the uptake of microfluidics, efforts directed towards rare forms of cancer, standardizing of CTC assays, broadening the scope of CTC-dependent clinical trials, and the knock-on effects of economic and expanding market growth. Key trends in the anticipated period involve the evolution of CTC isolation techniques, heightened government funding for CTC related research, progress in CTC detection technology, the increased usage of liquid biopsies for tracking cancer, dovetailing with single-cell analysis and the incorporation of artificial intelligence technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Circulating Tumor Cells Market?

The escalating rates of cancer are poised to fuel the growth of the circulating tumor cells market. Cancer is a condition characterized by the uncontrolled growth and spread of certain body cells. Circulating tumor cells play a crucial role in the early detection and diagnosis of this disease, thereby driving the market’s expansion. For example, the American Cancer Society Journals, a voluntary health body based in the U.S., anticipated in January 2023 that the country would experience 1,958,310 new cancer diagnoses and 609,820 cancer-related fatalities. Consequently, the increasing prevalence of cancer is a major driving force for the expansion of the circulating tumor cells market.

Which Key Market Segments Comprise the Circulating Tumor Cells Market and Drive Its Revenue Growth?

The circulating tumor cellsmarket covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Which Areas Are Leading Regions in the Circulating Tumor Cells Market Expansion Across the Globe?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theCirculating Tumor Cells Market Over the Coming Years?

Key advancements in product development are becoming a growing trend in the circulating tumor cells market. Major players in this sector are prioritizing the creation of pioneering products to cement their market presence. As an illustration, Bio-Rad Laboratories, Inc., a medical laboratory based in the US, introduced the Celselect Slides 2.0 in June 2024. This product is designed to elevate the capture of rare cells and circulating tumor cells (CTCs), thereby improving the precision and efficiency of cell analysis across clinical and research sectors.

View the full report here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

How Is the Circulating Tumor Cells Market Conceptually Defined?

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model